OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Elevated platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with polymyositis/dermatomyositis: a retrospective study
Meiqi Li, Suyan Yan, Rongrong Dong, et al.
Clinical Rheumatology (2023) Vol. 42, Iss. 6, pp. 1615-1624
Closed Access | Times Cited: 7
Meiqi Li, Suyan Yan, Rongrong Dong, et al.
Clinical Rheumatology (2023) Vol. 42, Iss. 6, pp. 1615-1624
Closed Access | Times Cited: 7
Showing 7 citing articles:
Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress
Xin Lu, Qinglin Peng, Guochun Wang
Nature Reviews Rheumatology (2023) Vol. 20, Iss. 1, pp. 48-62
Closed Access | Times Cited: 51
Xin Lu, Qinglin Peng, Guochun Wang
Nature Reviews Rheumatology (2023) Vol. 20, Iss. 1, pp. 48-62
Closed Access | Times Cited: 51
The Risk Factors of Refractory Adult‐Onset Still’s Disease
Lin Cheng, He-xiang Zong, Dongxu Li, et al.
International Journal of Hepatology (2025) Vol. 2025, Iss. 1
Open Access
Lin Cheng, He-xiang Zong, Dongxu Li, et al.
International Journal of Hepatology (2025) Vol. 2025, Iss. 1
Open Access
Dermatomyositis: Practical Guidance and Unmet Needs
Lydia Cassard, Noelle Seraly, Maureen Riegert, et al.
ImmunoTargets and Therapy (2024) Vol. Volume 13, pp. 151-172
Open Access | Times Cited: 3
Lydia Cassard, Noelle Seraly, Maureen Riegert, et al.
ImmunoTargets and Therapy (2024) Vol. Volume 13, pp. 151-172
Open Access | Times Cited: 3
Neutrophils in cancer drug resistance: Roles and therapeutic opportunities
Hao Liu, Hongyu Zhao, Mingzhen Zhou, et al.
Cancer Letters (2024) Vol. 611, pp. 217417-217417
Closed Access | Times Cited: 3
Hao Liu, Hongyu Zhao, Mingzhen Zhou, et al.
Cancer Letters (2024) Vol. 611, pp. 217417-217417
Closed Access | Times Cited: 3
Prognostic significance of natural killer cell depletion in predicting progressive fibrosing interstitial lung disease in idiopathic inflammatory myopathies
Chenyi Shao, Nana Xia, Yan Zhen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Chenyi Shao, Nana Xia, Yan Zhen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Predictors of rapidly progressive interstitial lung disease and prognosis in Chinese patients with anti-melanoma differentiation-associated gene 5-positive dermatomyositis
Meiqi Li, Xuli Zhao, Baocheng Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Meiqi Li, Xuli Zhao, Baocheng Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
The clinical value of KL-6 for predicting the occurrence and severity of connective tissue disease-associated interstitial lung disease is not affected by CTD type or treatment
Huifang Xing, Hongping Liang
PeerJ (2024) Vol. 12, pp. e17792-e17792
Open Access
Huifang Xing, Hongping Liang
PeerJ (2024) Vol. 12, pp. e17792-e17792
Open Access
